Painreform Ltd  (PRFX)
Other Ticker:  

 PRFX $0.7571 $0.1541 25.56%

 Volume (M): 3,272   Open : 0.63    52 Wk Avg :  2.80

 PRFX $0.7571 $0.1541 25.56%

 Volume (M): 3,272   Open : 0.63    52 Wk Avg :  2.80

PRFX Today's High: $0.7571 PRFX Shares One Week Perf: 14.54 %
PRFX Today's Low: $ 0.61 PRFX Shares 30 Day Performance: -7.67 %
Number of PRFX Shares Traded (M): 3,272 PRFX Share Price 52 Wk High: $ 26.41
Value of PRFX's Shares Traded (M$): $ 2,477 PRFX Share Price 52 Wk Avg: $2.80
Share Price at the Open: $0.63 PRFX's Share Price 52 Wk Low: $0.42

  News about Painreform Ltd's Stock Splits and Dividends

Navigating Uncertainty: PainReform Ltd's Path to Compliance and Resilience

PainReform Ltd Announces Non-Compliance with Nasdaq Listing Requirements
PainReform Ltd, a clinical-stage specialty pharmaceutical company, recently received a letter from the Nasdaq Listing Qualifications indicating that the Company is not in compliance with the minimum bid price requirement for continued listing. The requirement, set forth in Listing Rule 5550(a)(2), mandates that listed securities maintain a minimum bid price of $1.00 per share.
This notification has raised concerns among investors and stakeholders regarding PainReform Ltd's financial stability and market standing. The Company's failure to meet the minimum bid price requirement could potentially lead to delisting from the Nasdaq exchange, posing a significant threat to its future operations and credibility in the pharmaceutical industry.

PainReform Successfully Closes Public Offering, Raises Significant Funds for Clinical Development

TEL AVIV, Israel - PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, has recently announced the successful closing of its public offering. The company raised an aggregate of 5,000,000 ordinary shares and warrants at a combined public offering price of $0.80 per share. Additionally, PainReform recently exercised certain outstanding warrants, further bolstering its financial position. These developments mark a significant milestone for the company as it continues to advance its clinical programs and drive innovation in pain management.
Closing of Public Offering:
PainReform's recent public offering has garnered substantial investor interest, enabling the company to raise significant funds for further clinical development. The offering consisted of 5,000,000 ordinary shares (or ordinary share equivalents) and warrants to purchase up to 5,000,000 ordinary shares, priced at $0.80 per share (or per ordinary share equivalent) and accompanying warrant. The warrants, which are exercisable immediately upon issuance, have an exercise price of $0.80 per share and a term of five years.


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com